SEC Form 4 · accession 0001237899-15-000043
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Landry
Officer — SVP Finance & CFO
Period of report
Aug 5, 2015
Accepted (ET)
Aug 6, 2015 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2015 | M | 4,000 | $272.70 | A | 11,099 | D | |
| Common StockF1 | Aug 5, 2015 | S | 400 | $591.78 | D | 10,699 | D | |
| Common StockF2 | Aug 5, 2015 | S | 1,500 | $592.36 | D | 9,199 | D | |
| Common StockF3 | Aug 5, 2015 | S | 2,100 | $593.38 | D | 7,099 | D | |
| Common Stock | holding | — | — | — | 35 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $272.70 | Aug 5, 2015 | M | 4,000 | D | — | Sep 9, 2023 | Common Stock | 4,000 | 66,000 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 400 shares of Company stock on August 5, 2015 at prices ranging from $591.64 to $591.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F2Represents volume-weighted average price of sales of 1,500 shares of Company stock on August 5, 2015 at prices ranging from $592.02 to $592.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 2,100 shares of Company stock on August 5, 2015 at prices ranging from $593.00 to $593.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F4The stock option award vests in four equal annual installments, commencing one year after the date of grant.